94 results about "Enteric disease" patented technology

The invention discloses a method for preparing butyric acid bacteria powder by microencapsulated propagation culture and application, which belong to the technical field of microbial agents. In the invention, an initial strain is clostridium butyricunm JSIM-MCB20040312 with the preservation number of CGMCC (China General Microbiological Culture Collection) No.1647; the butyric acid bacteria powder is prepared by the steps of activation of butyric acid bacteria seeds, microencapsulated embedding of the butyric acid bacteria seeds, viable counting and preparation of butyric acid bacteria powder, wherein the concentration of the obtained bacteria powder is not less than 1.0*1011 / g. The viable organism propagation capacity of the butyric acid bacteria subjected to microencapsulated embedding is enhanced; a strict anaerobic environment created by liquid sealing of nitrogen gas or carbon diode and other inert gases or paraffin is avoided; a high-concentration bacteroid can be obtained without introducing air into a general fermentation tank for culturing; the production cost is low and the requirement for fed microbial additives on viable count can be met; the butyric acid bacteria powder also has the characteristics of heat resistance, acid resistance and favorable entericsolubility and is suitably used as animal intestine probiotics; and intestinal diseases of livestock and poultry farming animals such as chicken, pigs and the like are effectively prevented and the growth of the bred animals is promoted.

Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains.

The present invention relates to a livestock and poultry feed, and especially to a green livestock and poultry feed containing pine needle powder, and a preparation method thereof. The green livestock and poultry feed is prepared from the following raw materials, by weight, 1500-2000 parts of pine needle, 800-1100 parts of dandelion, 1200-1700 parts of beanstalks, and 4000-4500 parts of water. The green livestock and poultry feed of the present invention has characteristics of rich nutrient, feed saving and cost reducing, and provides significant effects for promotion of livestock and poultry growth and development, increase of disease resistance, and improvement of reproductive function. With the green livestock and poultry feed of the present invention, the disadvantages of low protein content and high digestive ability in the general farm feed and the market premix feed can be overcome, the appetite of the livestock and poultry can be effectively stimulated, the digestion-absorption and the metabolism can be promoted, the feed utilization rate can be increased, the growth and development of the livestock and poultry can be accelerated, the disease resistance can be increased, and the morbidities of the gastrointestinal diseases and the vitamin deficiency can be reduced.

A dietary and vitamin supplement, in capsule or powder form, for enhancing and maintaining digestive health and colon care, and alleviating gastrointestinal disorders, includes a blend of natural ingredients, including acidophilus, digestive enzymes and antioxidants, and which can be taken on an as-needed basis, in either capsule or liquid form, along with any other medications prescribed for the individual.

The invention discloses a preparation method of feed for fattening a yellow weasel quickly. The feed comprises chicken powder, pork powder, chicken liver powder, grass carp meat, silkworm chrysalis, corn powder, bran, radish powder, chicken wing powder, bone powder, milk powder, cod-liver oil, yeast, vitamins, angelica sinensis powder, liquorice powder, medlar powder and poria cocos powder, and the percentage is a weight percentage. The feed for the yellow weasel prepared by the formula is good in palatability, and can be absorbed easily; the growth speed is high; the disease resistance is high; the yellow weasel fed by the feed grows fast, and is large and healthy; and the preparation method effectively overcomes the defects that the growth and development of the yellow weasel are slow, the motility of young yellow weasels is high, and enteric diseases and constipation are caused easily to result in the death of the yellow weasel, due to the fact that the yellow weasel eats viscera of livestock for a long time, resulting in that the feed is single and is lack of nutrition required by the yellow weasel.

Bacteria of the sp. Bacillus that produce a lipopeptide are found to be effective in the treatment and prophylaxis of gastro-intestinal disease when administered as a probiotic. In particular, a strain of Bacillus bacteria identified as PB6 is useful for the treatment of Antibiotic Associated Diarrhea (AAD) or the more serious condition Clostridium difficile associated diarrhea (CDAD) when administered as a probiotic. Additionally, these bacteria have been found efficient for the treatment of immunorelated diseases such as Inflammatory Bowel Disease (IBD).

The invention provides a natural feed additive with functions of relieving diarrhea, resisting bacteria and eliminating inflammation. The natural feed additive is formed by main drugs and optional auxiliary materials, wherein the main drugs comprise the components in parts by weight: 5-40 parts of geranium wilfordii, 5-40 parts of houttuynia cordata, 2-15 parts of garden burnet, 2-35 parts of gallnut, 2-20 parts of radix berberidis or golden cypress and 1-20 parts of liquorice, and 0.5-10 parts of radix scutellariae, 1-8 parts of perfoliote knotweed herb, 5-10 parts of pileostegia viburnoides, 2-30 parts of purslane and 2-18 parts of cortex acanthopanacis (root, stem and / or leaf) can be added to the main drugs. The feed additive can be used for preventing or treating the respiratory diseases or enteric diseases of the domestic animals, especially the pneumonia or dysentery.

A method and apparatus for the differentiation of Crohn's disease from other gastrointestinal illnesses, such as ulcerative colitis and irritable bowel syndrome, using the presence of fecal anti-Saccharomyces cerevisiae antibodies (ASCA) as a marker for Crohn's disease are provided. The apparatus includes an enzyme-linked immunoassay or other immunoassay that utilizes antibodies specific to human immunoglobins for the measurement of total endogenous ASCA in a human fecal sample. The method and apparatus may be used by healthcare providers to distinguish Crohn's disease from other gastrointestinal illnesses, such as ulcerative colitis and irritable bowel syndrome.

The present invention provides a method of treatment or prophylaxis of enteric disease caused by Gram negative bacteria. The method includes the step of administering a vaccine or a hyperimmune material raised against said vaccine to an individual. The vaccine comprises one or more cell wall antigens reactive in a manner characteristic of O group serotypes, or reactive in a manner characteristic of lipopolysaccharide associated antigens, and at least some of said antigens are separated from bacterial cell walls or wall fragments. The invention also provides composition containing hyperimmune material as well as uses of the composition and vaccine.

The invention discloses a strain Anaerostipes sp B2131. The strain Anaerostipes sp B2131 has a collection number of CGMCC No. 1. 5295. The invention further simultaneously discloses application of thestrain Anaerostipes sp B2131 in preparation of drugs for preventing and / or treating inflammatory intestinal diseases. The enteric canal separated bacterium disclosed by the invention can be applied to products such as pharmaceutical compositions, foods, healthcare products and food additives as a probiotics preparation and is used for regulating a stable state of enteric canal florae and preventing and treating occurrence of enteric canal diseases such as the inflammatory intestinal diseases.